Spotlight: Savannah Doliboa, Chief Commercial Officer at CTI

In this episode of “Moving Medicine Forward,” SavannahDoliboa, Chief Commercial Officer at CTI, shares her career journey and what led her to CTI, a company that combines the strengths of both large and mid-sized CROs. She reflects on the rewards of working with rare disease sponsors, CTI’s diverse client base, and its reputation for flexibility, expertise, and lasting partnerships. Savannah also highlights CTI’s global growth and commitment to advancing clinical research through innovation and collaboration, while navigating regulatory challenges and embracing trends such as AI and patient-centricity.

00:52 Savannah shares her career journey and what led her to join CTI, highlighting her experience at both large and mid-sized CROs and how CTI offered the best of both worlds.

02:39 She discusses what makes working with rare disease sponsors so personally and professionally rewarding, particularly the close connection to patient communities.

03:57 Savannah outlines who CTI’s clients are, explaining that they range from biotech startups to large pharmaceutical companies, with a common thread of complexity and innovation.

04:46 She explains why clients choose CTI, citing the company’s niche expertise, flexibility, and ability to retain skilled team members throughout long and complex trials.

05:48 Savannah talks about how CTI’s agility helps meet client needs, especially when navigating regulatory challenges or changing trial strategies mid-study.

06:33 She identifies current trends in the clinical research industry, such as AI and reducing patient burden, that are creating new opportunities for both CTI and its clients.

07:51 Savannah shares how CTI’s global growth strategy aligns with its mission to go where clients need them most, supported by a strong track record of repeat businessand comprehensive services.

08:56 From a commercial lens, she explains where CTI is headed in the next 3–5 years, emphasizing innovation, quality partnerships, and staying at the forefront of clinical research.

09:33 She sums up why clients choose to work with CTI: a trusted mid-sized partner that delivers global reach, personalized service, and an extensive commitment tobringing treatments to market.